Abstract
Raf-1 is a serine-threonine protein kinase that functions as a central component of the mitogen-activated protein kinase signal transduction pathway. Raf-1 activity is currently assayed in vitro by either measuring 32P incorporation into MEK, Raf-1’s only characterized substrate, or by using the phosphorylated MEK to initiate a coupled assay culminating in the phosphorylation of myelin basic protein by MAP kinase. These assays are plagued by a potential lack of specificity in the case of the former, and the time consuming and error-prone nature of the later indirect assay. In this report, we demonstrate a novel single step assay for Raf-1 kinase activity based on phosphorylation of recombinant MEK-1, detected using an activation-specific MEK antibody that recognizes MEK only when specifically phosphorylated by Raf-1 on Ser 217 and Ser 221. The assay readily detected stem cell factor-mediated Raf-1 activation. MEK phosphorylation by immunoprecipitated Raf-1 plateaued at 10 min following initiation of the kinase reaction and was completely dependent on the inclusion of Raf-1. There was a linear correlation between the degree of MEK phosphorylation and the amount of Raf-1 protein immunoprecipitated. In addition to detecting growth factor-mediated activation, the assay was also able to detect paclitaxel-mediated Raf-1 activation. This assay is rapid, sensitive, and specific and therefore is a marked improvement over currently utilized techniques.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alessi DR, Saito Y, Campbell DG, Cohen P, Sithanandam G, Rapp U, Ashworth A, Marshall CJ and Cowley S. . 1994 EMBO J. 13: 1610–1619.
Alessi DR, Cohen P, Ashworth A, Cowley S, Leevers SJ and Marshall CJ. . 1995 Meth. In Enzym. 255: 279–290.
Anborgh PH, Qian X, Papageorge AG, Vass WC, DeClue JE and Lowy DR. . 1999 Mol. Cell. Biol. 19: 4611–4622.
Avruch J, Zhang XF and Kyriakis JM. . 1994 Trends Biochem. Sci. 19: 279–283.
Bhalla K, Ibrado AM, Tourkina E, Tang C, Mahoney ME and Huang Y. . 1993 Leukemia 7: 563–568.
Blagosklonny MV, Schulte TW, Nguyen P, Mimnaugh EG, Trepel J and Neckers L. . 1995 Cancer Res. 55: 4623–4626.
Brunet A, Pagès G and Pouysségur J. . 1994 FEBS Lett. 346: 299–303.
Cowley S, Paterson H, Kemp P and Marshall CJ. . 1994 Cell 77: 841–852.
Dent P, Haser W, Haystead TAJ, Vincent LA, Roberts TM and Sturgill TW. . 1992 Science 257: 1404–1407.
Fabian JR, Daar IO and Morrison DK. . 1993 Mol. Cell. Biol. 13: 7170–7179.
Jelinek T, Dent P, Sturgill TW and Weber MJ. . 1996 Mol. Cell. Biol. 16: 1027–1034.
Krystal GW, DeBerry CS, Linnekin D and Litz J. . 1998 Cancer Res. 58: 4660–4666.
Kyriakis JM, App H, Zhang XF, Banerjee P, Brautigan DL, Rapp UR and Avruch J. . 1992 Nature 358: 417–421.
Kyriakis JM, Force TL, Rapp UR, Bonventre JV and Avruch J. . 1993 J. Biol. Chem. 268: 16009–16019.
Lewis TS, Shapiro PS and Ahn NG. . 1998 Adv. Cancer Res. 74: 49–139.
Lou Z, Diaz B, Marshall MS and Avruch J. . 1997 Mol. Cell. Biol. 17: 46–53.
Manffredi JJ and Horwitz SB. . 1984 Pharmacol. Ther. 25: 83–125.
Marias R, Light Y, Paterson HF and Marshall CJ. . 1995 EMBO J. 14: 3136–3145.
Okuda K, Sanghera JS, Pelech SL, Kanakura Y, Hallek M, Griffin JD and Drucker BJ. . 1992 Blood 79: 2880–2887.
Rapp UR, Goldsborough MD, Mark GE, Bonner TI, Groffen J, Reynolds Jr FH and Stephenson JR. . 1983 Proc. Natl. Acad. Sci. USA. 80: 4218–4222.
Robinson MJ and Cobb MH. . 1997 Curr. Opin. Cell Biol. 9: 180–186.
Rowinsky EK, Donehower RC, Jones RJ and Tucker RW. . 1988 Cancer Res. 48: 4093–4100.
Roy S, Lane A, Yan J, McPherson R and Hancock JF. . 1997 J. Biol. Chem. 272: 20139–20145.
Saito Y, Gomez N, Campbell DG, Ashworth A, Marshall CJ and Cohen P. . 1994 FEBS Lett. 341: 119–124.
Torres K and Horwitz SB. . 1998 Cancer Res. 58: 3620–3626.
Van Aelst L, Barr M, Marcus S, Polverino A and Wigler M. . 1993 Proc. Natl. Acad. Sci. USA. 90: 6213–6217.
Vojtek AB, Hollenberg SM and Cooper JA. . 1993 Cell 74: 205–214.
Wartmann M and Davis RJ. . 1994 J. Biol. Chem. 269: 6695–6701.
Zheng CF and Guan KL. . 1994 EMBO J. 13: 1123–1131.
Acknowledgements
This work was supported by a Veterans Administration Merit Review Award to Geoffrey W Krystal and PHS grants CA83705 and CA63753 to Steven Grant.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bondzi, C., Grant, S. & Krystal, G. A novel assay for the measurement of Raf-1 kinase activity. Oncogene 19, 5030–5033 (2000). https://doi.org/10.1038/sj.onc.1203862
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203862
Keywords
This article is cited by
-
Abl kinase regulation by BRAF/ERK and cooperation with Akt in melanoma
Oncogene (2017)
-
Inhibition of RAS function through targeting an allosteric regulatory site
Nature Chemical Biology (2017)
-
BCR/ABL and IL-3 activate Rap1 to stimulate the B-Raf/MEK/Erk and Akt signaling pathways and to regulate proliferation, apoptosis, and adhesion
Oncogene (2006)
-
High oleic acid oil suppresses lung tumorigenesis in mice through the modulation of extracellular signal‐regulated kinase cascade
Lipids (2002)